Cited by 209Sirtuins and Resveratrol in MedicinePhytochemicals and Antioxidant ActivitiesAlzheimer's disease research and treatments

The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer’s disease pathology: From antioxidant to epigenetic therapy

Open access
Griñán-Ferré, Christian, Bellver-Sanchis, Aina, Izquierdo, Vanessa, Corpas, Rubén, Roig-Soriano, Joan, Chillón, Miguel, Andres-Lacueva, Cristina, Somogyvári, Milán +3 more·2021·Ageing Research Reviews

Abstract

While the elderly segment of the population continues growing in importance, neurodegenerative diseases increase exponentially. Lifestyle factors such as nutrition, exercise, and education, among others, influence ageing progression, throughout life. Notably, the Central Nervous System (CNS) can benefit from nutritional strategies and dietary interventions that prevent signs of senescence, such as cognitive decline or neurodegenerative diseases such as Alzheimer's disease and Parkinson's Disease. The dietary polyphenol Resveratrol (RV) possesses antioxidant and cytoprotective effects, producing neuroprotection in several organisms. The oxidative stress (OS) occurs because of Reactive oxygen species (ROS) accumulation that has been proposed to explain the cause of the ageing. One of the most harmful effects of ROS in the cell is DNA damage. Nevertheless, there is also evidence demonstrating that OS can produce other molecular changes such as mitochondrial dysfunction, inflammation, apoptosis, and epigenetic modifications, among others. Interestingly, the dietary polyphenol RV is a potent antioxidant and possesses pleiotropic actions, exerting its activity through various molecular pathways. In addition, recent evidence has shown that RV mediates epigenetic changes involved in ageing and the function of the CNS that persists across generations. Furthermore, it has been demonstrated that RV interacts with gut microbiota, showing modifications in bacterial composition associated with beneficial effects. In this review, we give a comprehensive overview of the main mechanisms of action of RV in different experimental models, including clinical trials and discuss how the interconnection of these molecular events could explain the neuroprotective effects induced by RV.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.arr.2021.101271

Cites

473 of 473 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

10 of the 483 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Berman, A.Y., Motechin, R.A., Wiesenfeld, M.Y., Holz, M.K., 2017. The therapeutic potential of resveratrol: a review of clinical trials. Npj Precis. Oncol. 1.

Cited by

Sorted by citations

Authors
Griñán-Ferré, C., Bellver-Sanchis, A., Izquierdo, V., Corpas, R., Roig-Soriano, J., Chillón, M., Andres-Lacueva, C., Somogyvári, M., Sőti, C., Sanfeliu, C., & Pallàs, M.
Affiliations
  • Universitat de Barcelona (ES)
  • Institut d'Investigacions Biomèdiques de Barcelona (ES)
  • Universitat Autònoma de Barcelona (ES)
  • Institució Catalana de Recerca i Estudis Avançats (ES)
  • Semmelweis University (HU)
Venue
Ageing Research Reviews
Publisher
Elsevier BV
Published
2021-05
Volume
67
Pages
101271
ISSN
1568-1637 (ISSN-L)
OpenAlex
W3126884725
Cited by
208
References
483
Citations by year
2026: 15 · 2025: 33 · 2024: 52 · 2023: 47 · 2022: 38 · 2021: 22 · 2020: 1
FWCI
5.93
Type
journal article
Language
en
Open access
Locations
  • Ageing Research Reviews (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
Funders
  • European Regional Development Fund (PCIN-2015-229, PID2019-106285RB)
  • Spain Ministry of Science and Innovation
  • Hungarian Science Foundation
  • Semmelweis Egyetem (STIA-KFI-2020/132257/AOMBT/2020)
  • Ministry of Economic Affairs and Digital Transformation
  • Government of Catalonia (2017 SGR 106)
  • Agencia Estatal de Investigación
  • Ministerio de Economía y Competitividad
  • Hungarian Scientific Research Fund (K 116525)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
resveratrol, neuroprotection, cognitive decline, Alzheimer's disease, Parkinson's disease, oxidative stress, reactive oxygen species, epigenetic modifications, aging, gut microbiota, dietary polyphenols, mitochondrial dysfunction, neuroinflammation, apoptosis, DNA damage, antioxidant activity
MeSH terms
Resveratrol, Aged, Alzheimer Disease, Antioxidants, Humans, Oxidative Stress, Neuroprotective Agents, Epigenesis, Genetic, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review